Lipid metabolism and immunosuppressive therapy in heart transplant recipients

Transplantation Proceedings

Volumn 35, Issue 2, 2003, Pages 677-

  Berman, Marius ^a,b   Ben Gal, T ^a   Stamler, A ^a   Kogan, A ^a   Shapira, Y ^a   Sagie, A ^a   Saute, M ^a   Kramer, M ^a   Aravot, D ^a   Vidne, B ^a   Sahar, G ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHOLESTEROL; CYCLOSPORIN A; STATIN; TACROLIMUS;

CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG WITHDRAWAL; FOLLOW UP; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIPID METABOLISM; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

EID: 0037339181     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(03)00094-0     Document Type: Conference Paper

References (6)

1. Bittar A.E., Ratcliffe P.J., Richardson A.J., et al. Transplantation. 50:1990;987.
2. Lindholm A., Albrechtsen D., Frodin L., et al. Transplantation. 60:1995;451.
3. Kuster G.M., Drexel H., Bleisch J.A., et al. Transplantation. 63:1994;1479.
4. Fernandez-Miranda C., Guijarro C., de la Calle A., et al. Transpl Int. 11:1998;137.
5. Ichimaru N., Takahara S., Kokado Y., et al. Atherosclerosis. 158:2001;417.
6. Copley J.B., Staffeld C., Lindberg J., et al. Transplant Proc. 30:1998;1254.